N0539 phase ii trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: A north central cancer treatment group (now alliance) trial

W. W. Tan, A. C. Dueck, P. Flynn, P. Steen, D. Anderson, K. Rowland, D. Northfelt, E. A. Perez

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'N0539 phase ii trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: A north central cancer treatment group (now alliance) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences